Prof. Dr. Gisela Degen

Wissenschaftliche Mitarbeiterin

Publikationen

Hier finden Sie die Publikationen ab 2010, die am IfADo entstanden sind.

Metzler M, Bitsch A, Degen GH:

The life of Hans-Günter Neumann and his contributions to chemical carcinogenesis. (Guest editorial). Arch Toxicol 94: 1773-1778 (2020)

Ali N, Manirujjaman M, Rana S, Degen GH:

Determination of aflatoxin M1 and deoxynivalenol biomarkers in infants and children urines from Bangladesh. Arch Toxicol 94: 3775–3786 (2020)

Ali N, Degen GH:

Biological monitoring for ochratoxin A and citrinin and their metabolites in urine samples of infants and children in Bangladesh. Mycotoxin Res 36: 409-417 (2020)

Ali N, Degen GH:

Biomonitoring of zearalenone and its main metabolites in urines of Bangladeshi adults. Food Chem Toxicol 130: 276–283 (2019)

Malir F, Louda M, Ostry V, Toman J, Ali N, Grosse Y, Malirova E, Pacovsky J, Pickova D, Brodak M, Pfohl-Leszkowicz A, Degen GH:

Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours. Mycotoxin Res 35: 391-403 (2019)

Ali N, Degen GH:

Citrinin biomarkers: a review of recent data and application to human exposure assessment. Arch Toxicol 93: 3057-3066 (2019)

Ali N, Hossain K, Degen GH:

Blood plasma biomarkers of citrinin and ochratoxin A exposure in young adults in Bangladesh. Mycotoxin Res 34: 59–67 (2018)

Ali N, Degen GH:

Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults. Arch Toxicol 92: 2691-2700 (2018)

Degen GH:

Biomarker-based assessment of human exposure to citrinin. In: Max Rubner-Institut, MRI (Hrsg.): Max Rubner Conference 2018 “Fungi and mycotoxins in foods”. Karlsruhe, October 8-10, 2018, Speaker abstracts (p 21). Karlsruhe: MRI, 2018

Braun D, Ezekiel CN, Abia WA, Wisgrill L, Degen GH, Turner PC, Marko D, Warth B:

Monitoring Early Life Mycotoxin Exposures via LC-MS/MS Breast Milk Analysis. Anal Chem 90: 14569-14577 (2018)

Scientific Committee on Consumer Safety (SCCS), Rousselle C, Degen G [u. a.]:

Opinion of the Scientific Committee on Consumer Safety (SCCS) – Final version of the opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products. Regul Toxicol Pharmacol 83: 117-118 (2017)

Scientific Committee on Consumer Safety (SCCS), Rousselle C, Degen G [u. a.]:

Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products. Regul Toxicol Pharmacol 84: 102-104 (2017)

Solecki R, Kortenkamp A, Bergman Å, Chahoud I, Degen GH, Dietrich D, Greim H, Håkansson H, Hass U, Husoy T, Jacobs M, Jobling S, Mantovani A, Marx-Stoelting P, Piersma A, Ritz V, Slama R, Stahlmann R, van den Berg M, Zoeller RT, Boobis AR:

Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement. Arch Toxicol 91: 1001-1006 (2017)

Munoz K, Cramer B, Dopstadt J, Humpf H-U, Degen GH:

Evidence of ochratoxin A conjugates in urine samples from infants and adults. Mycotoxin Res 33: 39-47 (2017)

Ali N, Blaszkewicz M, Hossain K, Degen GH:

Determination of aflatoxin M1 in urine samples indicates frequent dietary exposure to aflatoxin B1 in the Bangladeshi population. Int J Hyg Environ Health 220: 271-281 (2017)